Matrix metalloproteinase-2 dysregulation in type 1 diabetes. - Wikidata - awgldk - TriplyDB

Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

http://www.wikidata.org/entity/Q36454493

about

Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers Diabetic nephropathy and extracellular matrix The restorative role of annexin A1 at the blood-brain barrier.Loss of compliance in small arteries, but not in conduit arteries, after 6 weeks exposure to high fat diet.Matrix metalloproteinases in subjects with type 1 diabetes Intraocular pressure and aqueous humor flow during a euglycemic-hyperinsulinemic clamp in patients with type 1 diabetes and microvascular complications Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling.Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy Effects of reduced β2-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice.Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus.Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency?Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.A glimpse of matrix metalloproteinases in diabetic nephropathy.Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin.Dysregulation of the intrarenal vitamin D endocytic pathway in a nephropathy-prone mouse model of type 1 diabetes.Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study The α7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells.Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients.Urinary matrix metalloproteinase activity in diabetic kidney disease: a potential marker of disease progression.Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.The serum protein fetuin-B is involved in the development of acute myocardial infarction.Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?Proteases in Plasma and Kidney of db/db Mice as Markers of Diabetes-Induced Nephropathy.Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.Loss of TIMP3 selectively exacerbates diabetic nephropathy.Genotype association of C(-735)T polymorphism of the MMP-2 gene with the risk of carotid atherosclerosis-vulnerable plaque in the Han Chinese population.Matrix metalloproteinase 14 modulates diabetes and Alzheimer's disease cross-talk: a meta-analysis.Urinary metalloproteinases and tissue inhibitors of metalloproteinases as potential early biomarkers for renal fibrosis in children with nephrotic syndrome.Proteins of TNF-α and IL6 Pathways Are Elevated in Serum of Type-1 Diabetes Patients with Microalbuminuria.Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy.Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients

P2860

Q24644869-68C91E71-BF9D-4082-8E4C-E5A5FCE65570 Q26996008-46EB6FE5-9A02-43D8-84F9-8CD190F5B2A5 Q27687514-2C97C92C-6ECC-413D-BEAE-78BD8473E23E Q30455320-AB939241-4346-471E-A84F-54E62523BDBB Q33503886-D31B2E41-0F34-4188-ACE9-9934472791C2 Q33614320-F57408C2-FA8C-4A84-9247-9D4845548516 Q33988848-82DE74D8-A2FC-4EEA-8F0B-56D8AB48E1DA Q34067504-88BE13D5-39C3-46E0-9356-936355E17FF3 Q34199412-B7B890AB-65D4-4D41-A9D8-9F4A58E6229A Q34222704-AA901E29-0989-4169-BCB5-00BA8C36EF73 Q34571836-F674CE71-A2A1-4EDE-BADE-9B6C3F30AF62 Q34784085-8F5EBEA1-EE78-4CBF-8B79-D5E45566E3CC Q34796034-E7A7689A-BA88-4E7F-8109-84157BE3CB20 Q34975684-52130B49-B5A0-4E8A-B471-4E2EE72C7B00 Q35070544-E87D7E91-F714-44AA-AEBC-978EA2201C55 Q35166512-9B13E045-4DD5-48B6-8B85-90BFEC326BDE Q35221001-13169B2F-E1FF-445A-B4F7-F2E884962A47 Q35819489-7F059B53-0C88-400E-A34F-AB622F7AEF8D Q36088748-2DCEE450-080E-4E88-AEF9-886DCE27C438 Q36206158-0C2119B4-1399-4FA0-8595-01959320A0BD Q36317621-5C098C15-61F0-4582-8887-BF8521C7294C Q37069135-BF38E7A7-B0D4-433B-97D6-91EC1E81B551 Q37195371-AE59A310-CA75-43C2-B905-219D274103CA Q38910796-B97D4C5C-AD62-4B4A-9ADC-95B32B2BB37F Q38942962-66EEE40B-3439-4BEA-AE08-F3B2706F6463 Q40549158-1C898055-B448-43B5-9E61-AB841FF59360 Q42290483-A137B56B-726E-4C88-A8CF-F20D1865C364 Q42402000-E14A8FF2-B588-4B92-B615-0478E21F398B Q44104267-EDF11EC9-E1C8-461B-8AD1-FE4A94F9D45E Q47380940-BF06AEEA-DC3E-4D77-A7C4-87679DD15A71 Q49711936-1C8639A1-8027-4710-9E0F-0973649363E1 Q50231029-84111256-ED60-44D4-AD83-D282D6C9C63E Q51045007-C50032E2-58C4-4207-9BAA-19372F35896C Q58217617-EAD47D6F-3100-4450-8808-CD0CD9C66228

P2860

Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

http://www.wikidata.org/entity/Q36454493

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

@ast

Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

@en

type

label

Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

@ast

Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

@en

prefLabel

Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

@ast

Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

@en

P1433

Q36454493-9A918AAB-D18B-48F8-8939-078D5346E101

P1476

Q36454493-0CA1A40E-FE4D-42C5-9483-B95FF6122B3E

P2093

Q36454493-26105A6A-0BB9-41DC-986D-770FB89FAE0D

Q36454493-30AD70A2-E2AE-4A45-8414-82CBF933BC07

Q36454493-59D2EF4E-B96B-4BDE-8ED8-28A7D11DEC8A

Q36454493-75E7436D-1187-4E1A-8B40-F60F99AF3CAB

Q36454493-90E8E0CB-796D-4BF6-94A0-855BE14B5A70

Q36454493-9F438898-588D-4821-A5F7-B85C404128F4

Q36454493-AE9406BB-570C-4781-9AF6-77969DBAD55F

Q36454493-DF2F91CE-B748-4EA3-9BC0-F8CBD5C0D8AF

Q36454493-E86ABF4F-BCAD-40A6-AAB7-8E874FC2441D

P2860

Q36454493-110BE466-66C3-434B-B1CC-2BF6E68CB45D

Q36454493-125373CC-885F-42EB-A441-C153F09BC033

Q36454493-2455D7D9-FC8A-4038-90A0-F6A962565D97

Q36454493-354C35EA-F7DB-44E1-ABEC-0E4544240DED

Q36454493-363D79DB-AF5A-4537-B511-A8D2982BF90A

Q36454493-370A2FB2-CE64-47EA-A65C-E7E6FA24E55F

Q36454493-3E19A6E6-D133-49D7-B2C8-8BB2B7B051DC

Q36454493-54DB31ED-C668-492A-847F-21AA5820598C

Q36454493-55B090EA-3CFA-4DCE-B07A-1FB890AF8284

Q36454493-63139B9D-8AA2-4F8F-974A-69980A8D23E2

P304

Q36454493-975F2BE3-3FD4-4F29-BA33-4FD78274B6D0

P31

Q36454493-2FBF34AA-172D-4727-B329-C44BAE66F045

P356

Q36454493-EBF0B2F9-B77E-4F10-A9D5-134F3B49D239

P407

Q36454493-73B5909E-FBA7-46BE-8196-79B274971DEC

P433

Q36454493-18EC31F9-0940-46EF-97D3-27B79186EA6A

P478

Q36454493-6E76D448-AF30-4EA8-AAFF-8AE8F17BAB2C

P577

Q36454493-B1C80516-99BA-41D0-824B-7EB6B594F540

P5875

Q36454493-BAEEFF1D-ED45-4A60-8F0D-3B5D715BA53E

P698

Q36454493-010DFDC0-B14E-47FA-A4EF-D1E081FF3B53

P921

Q36454493-A9A4C351-A73C-4AF5-9DCB-C722E611BDD9

P932

Q36454493-4B4FD04D-F6BB-4231-9B0C-8FF6D4A60211

P356

P1433

P1476

Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

@en

P2093

Cynthia S Moreau

http://www.w3.org/2001/XMLSchema#string

Gael E Cockrell

http://www.w3.org/2001/XMLSchema#string

Hannah N Coleman

http://www.w3.org/2001/XMLSchema#string

J Paul Frindik

http://www.w3.org/2001/XMLSchema#string

John L Fowlkes

http://www.w3.org/2001/XMLSchema#string

Kathryn M Thrailkill

http://www.w3.org/2001/XMLSchema#string

Pippa M Simpson

http://www.w3.org/2001/XMLSchema#string

Robert C Bunn

http://www.w3.org/2001/XMLSchema#string

Stephen F Kemp

http://www.w3.org/2001/XMLSchema#string

P2860

Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients

Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage.

The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis.

Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis.

Establishment of a diabetic mouse model with progressive diabetic nephropathy.

Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.

Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens.

An empirical comparison of expert-derived and data-derived classification trees.

P304

2321-2326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC07-0162

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6274352

http://www.w3.org/2001/XMLSchema#string

P698

17563344

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

2239013

http://www.w3.org/2001/XMLSchema#string